XML 78 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value of Financial Instruments
12 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

6. Fair Value of Financial Instruments

The Company’s financial instruments generally included cash and cash equivalents, short-term investments, a foreign currency forward contract, trade, notes and financing lease receivables and accounts payable.  Due to the short-term maturities of cash and cash equivalents, trade and other receivables and accounts payable, the carrying amounts approximate fair value on the respective balance sheet dates.  The valuation technique used to measure the fair value of the contingent consideration was derived from models utilizing market observable inputs.  

The Company measures short-term investments and derivatives at fair value on a recurring basis.

The following tables present the fair value of the Company’s short-term investments, contingent consideration and foreign currency forward contracts by valuation hierarchy and input (in thousands):

 

 

 

AS OF SEPTEMBER 30, 2019

 

 

 

Quoted Prices

in Active

Markets for

Identical Assets

(Level 1)

 

 

Significant Other

Observable

(Level 2)

 

 

Significant

Unobservable

(Level 3)

 

 

Totals

 

Contingent consideration

 

$

 

 

$

 

 

$

(9,940

)

 

$

(9,940

)

Foreign currency forward contract

 

 

 

 

 

(4

)

 

 

 

 

 

(4

)

Total

 

$

-

 

 

$

(4

)

 

$

(9,940

)

 

$

(9,944

)

 

 

 

AS OF SEPTEMBER 30, 2018

 

 

 

Quoted Prices

in Active

Markets for

Identical Assets

(Level 1)

 

 

Significant Other

Observable

(Level 2)

 

 

Significant

Unobservable

(Level 3)

 

 

Totals

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

17,791

 

 

$

 

 

$

 

 

$

17,791

 

Government bonds

 

 

7,680

 

 

 

 

 

 

 

 

 

7,680

 

Contingent consideration

 

 

 

 

 

 

 

 

(7,713

)

 

 

(7,713

)

Foreign currency forward contract

 

 

 

 

 

(270

)

 

 

 

 

 

(270

)

Total

 

$

25,471

 

 

$

(270

)

 

$

(7,713

)

 

$

17,488

 

 

Assets and liabilities measured on a nonrecurring basis

The measurements utilized to determine the implied fair value of the Company’s long-lived assets and contingent consideration as of September 30, 2019 represented significant unobservable inputs (Level 3).

 

The following table summarizes changes in the fair value of the Company’s Level 3 financial instruments for the fiscal year ended September 30, 2019:

 

Balance at October 1, 2018

 

$

7,713

 

Contingent consideration pursuant to acquisitions

 

 

4,342

 

Fair value adjustments

 

 

(2,115

)

Balance at September 30, 2019

 

$

9,940

 

 

Adjustments to the fair value of the contingent consideration are based on Monte Carlo simulations utilizing inputs which include market comparable information and management assessments regarding potential future scenarios.  The Company believes its estimates and assumptions are reasonable, however, there is significant judgement involved.